tirzepatide patient information for Medical Weight Loss Does Tirzepatide Cause Flu-Like Symptoms?

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients

The new weight-loss drugs have created a hope and optimism among my patients that I have frankly not seen before, says Sarah C

MRC Weight Loss Coaches will be there for you every step of the way

FDA approves Novo Nordisks oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults owenhaskins Oct 20, 2025 3 min read Novo Nordisk has received FDA approval for Rybelsus for reducing the risk of major adverse cardiovascular events (MACE) such as cardiovascular (CV) death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they've had a prior CV event or not (primary and secondary prevention)